ATE126209T1 - Sulfonylhydrazine und deren verwendung als antineoplastische und als antitrypanosomale mittel. - Google Patents

Sulfonylhydrazine und deren verwendung als antineoplastische und als antitrypanosomale mittel.

Info

Publication number
ATE126209T1
ATE126209T1 AT90114747T AT90114747T ATE126209T1 AT E126209 T1 ATE126209 T1 AT E126209T1 AT 90114747 T AT90114747 T AT 90114747T AT 90114747 T AT90114747 T AT 90114747T AT E126209 T1 ATE126209 T1 AT E126209T1
Authority
AT
Austria
Prior art keywords
sulfonylhydrazines
aryl
alkyl
antineoplastic
agents
Prior art date
Application number
AT90114747T
Other languages
English (en)
Inventor
Alan C Sartorelli
Alan A Divo
Krishnamurthy Shyam
Philip G Penketh
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of ATE126209T1 publication Critical patent/ATE126209T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90114747T 1989-09-06 1990-08-01 Sulfonylhydrazine und deren verwendung als antineoplastische und als antitrypanosomale mittel. ATE126209T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/403,533 US5101072A (en) 1989-09-06 1989-09-06 Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents

Publications (1)

Publication Number Publication Date
ATE126209T1 true ATE126209T1 (de) 1995-08-15

Family

ID=23596136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90114747T ATE126209T1 (de) 1989-09-06 1990-08-01 Sulfonylhydrazine und deren verwendung als antineoplastische und als antitrypanosomale mittel.

Country Status (9)

Country Link
US (1) US5101072A (de)
EP (1) EP0416286B1 (de)
JP (1) JPH03167168A (de)
AT (1) ATE126209T1 (de)
CA (1) CA2024523A1 (de)
DE (1) DE69021466T2 (de)
DK (1) DK0416286T3 (de)
ES (1) ES2076998T3 (de)
GR (1) GR3018021T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256820A (en) * 1991-11-08 1993-10-26 Yale University 1-alkyl-2-acyl-1,2-disulfonylhydrazines
US5637619A (en) * 1995-07-05 1997-06-10 Yale University Antitumor 2-aminocarbonyl-1, 2-bis(methylsulfonyl)-1-(substituted)hydrazines
US6040338A (en) * 1997-11-03 2000-03-21 Yale University N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents
US20020142941A1 (en) * 2001-03-30 2002-10-03 Pro Duct Health, Inc. Intraductal treatment targeting methylated promoters in breast cancer
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6855695B2 (en) * 2003-06-13 2005-02-15 Vion Pharmaceuticals, Inc. Water-soluble SHPs as novel alkylating agents
WO2005094282A2 (en) * 2004-03-26 2005-10-13 Vion Pharmaceuticals, Inc. Combination therapy comprising cloretazinetm
JP4814245B2 (ja) * 2004-09-21 2011-11-16 ヴァイオン ファーマシューティカルズ、インコーポレーテッド 低酸素選択性抗腫瘍剤としてのスルホニルヒドラジンのリン酸含有プロドラッグ
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1808173A1 (de) * 2006-01-12 2007-07-18 Matthias Dormeyer Verwendung von Krebsmitteln, die in das Zentralnervensystem eindringen, zur Behandlung protozoale Erkrankungen
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1069637B (de) * 1960-04-28 Farbenfabriken Bayer Aktiengesellschaft Leverkusen Bayerwerk Verfahren zur Herstellung von Hydraziden aliphatischer Sulfosäuren
US4209632A (en) * 1974-06-05 1980-06-24 Uniroyal, Inc. Sulfonyl carbazates
US4175200A (en) * 1975-04-11 1979-11-20 Uniroyal, Inc. N,N-Disubstituted sulfonyl hydrazines
US4684747A (en) * 1984-12-20 1987-08-04 Yale University N,N'-bis(sulfonyl)hydrazines having antineoplastic activity
US4849563A (en) * 1986-01-21 1989-07-18 Yale University Novel 1-alkyl-1-arenesulfonyl-2-alkoxycarbonylsulfenylhydrazines having antineoplastic activity

Also Published As

Publication number Publication date
JPH03167168A (ja) 1991-07-19
DE69021466D1 (de) 1995-09-14
US5101072A (en) 1992-03-31
ES2076998T3 (es) 1995-11-16
EP0416286A1 (de) 1991-03-13
EP0416286B1 (de) 1995-08-09
GR3018021T3 (en) 1996-02-29
DE69021466T2 (de) 1996-02-29
DK0416286T3 (da) 1995-12-11
CA2024523A1 (en) 1991-03-07

Similar Documents

Publication Publication Date Title
ATE126209T1 (de) Sulfonylhydrazine und deren verwendung als antineoplastische und als antitrypanosomale mittel.
ATE304848T1 (de) Verwendung von vier k-252a derivaten
ATE184789T1 (de) Verwendung von carnosolsäure wegen seiner anticarcinogenen und antiviralen eigenschaften
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
ATE92499T1 (de) Tumorbehandlung bei saeugetieren.
DE69330733D1 (de) 9-[(Substituierte Glycyl)amido]-6-demethyl-6-deoxytetracycline als antibiotische Mittel
DE68916359D1 (de) Arylendiamin-substituierte Pyrimidine.
FI902386A0 (fi) Nukleosidanaloger.
FI930977A0 (fi) Taxanderivat, deras framstaellning och onkologiska anvaendning
DE68903226D1 (de) Dideoxydidehydrocarbocyclische nukleoside.
DE69124844D1 (de) Radicicol-Derivate, ihre Herstellung und ihre Antitumorwirkung
DE59109117D1 (de) Fungizide Mittel
DK0574195T3 (da) Antitumor 5,8-dihydrodiazaanthracener
IT1252039B (it) Policondensati della 2,4,6-triammino-1,3,5-triazina come agenti antifiamma
ATE93846T1 (de) S-substituierte beta-thioacrylamide und deren verwendung als mikrobizide.
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
EP0721957A4 (de) Die verbindung ge3
ATE109773T1 (de) Acylierungsprodukte von 9,10-

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee